Xcelience, a contract development and manufacturing organization, has opened a 3,000-square facility in Birmingham, UK, which will become a gateway for the company's clinical packaging and distribution services in the UK, Europe, and abroad.

The facility offers storage, secondary packaging, labeling, and clinical trial distribution operations. Other capabilities include qualified person (QP) release and laboratory services. The new building also houses a qualified 2-8 °C walk-in cold-storage chamber. The UK Medicines and Healthcare Products Regulatory Agency (MHRA) fully inspected the new facility on June 4, 2014.

Xcelience corporate standard operating procedures (SOPs) have been revised to include the new UK/European Union (EU) operations. Several Xcelience clients have begun to schedule EU distribution of clinical materials for the third quarter of 2014.

The Xcelience facility in Birmingham is the first step in the company's multi-stage plan to develop and license several international hubs in places where clients most need them, said President and CEO Derek Hennecke in a company press release. Xcelience is actively working toward setting up partner depot facilities in four locations in Latin America, one in the Middle East, and one in Russia.

Xcelience provides preformulation, analytical services, formulation development, GMP manufacturing, small-scale commercial manufacturing, and clinical supplies packaging and logistics.

Source: Xcelience